next-generation sequencing

Research Reports

Off-Label Use of Precision Oncology Therapeutics in Advanced Solid Cancers Following Identification of Associated Variants via Multicancer Next-Generation Sequencing Panel: A Real-World Evidence Pilot Study

09/19/2023

Julie Wiedower, PhDc

Nicole Zhang, MPH

Rebecca Nagy, MS

Kathryn Lang, MD

Jayati Saha, PhD, MPH

Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.

Julie Wiedower, PhDc, and...

09/19/2023

Journal of Clinical Pathways

Review

NGS Testing in Non–Small Cell Lung Cancer

09/19/2023

Winston Wong, PharmD

Gordon Kuntz

Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...

Winston Wong, PharmD, and Gordon...

09/19/2023

Journal of Clinical Pathways

Conference Coverage

Tumor Mutation Burden Unlikely Biomarker for Checkpoint Inhibitor Response in CRC

02/03/2021

Journal of Clinical Pathways

News

Identifying Biomarkers for Relapsed, Refractory DLBCL Subtype

06/16/2020

A study presented at the European Hematology Association (EHA) Virtual Meeting (June 11-21, 2020) sought to identify biomarkers in patients with relapsed or refractory non-germinal center B-cell-like (non-GCB)...

A...

06/16/2020

Journal of Clinical Pathways

Superiority of Next-Generation Sequencing (NGS) over Quantitative Polymerase Chain Reaction (qPCR) Testing in Detecting Primary Pathogens of Polymicrobial Communities Found in Infected Chronic Foot Wounds

Chronic foot wounds, whether diabetic or nondiabetic, yield a multilayered, polymicrobial community of fast and slow growing aerobic and anaerobic bacteria, as well as fungus, yeast, and ...

11/27/2019